Market Tracker

10/18 10:41am ET
344.76
BATS BZX Real-Time Price
As of 10:40am ET
 +0.29 / +0.08%
Today’s Change
244.28
Today|||52-Week Range
348.65
+31.99%
Year-to-Date

Today’s Trading

Previous close344.47
Today’s open346.76
Day’s range344.74 - 348.29
Volume26,781
Average volume (3 months)1,362,839
Market cap$72.8B
Dividend yield--
Data as of 10:40am ET, 10/18/2017

Growth & Valuation

Earnings growth (last year)+10.32%
Earnings growth (this year)+6.39%
Earnings growth (next 5 years)+5.71%
Revenue growth (last year)+9.37%
P/E ratio22.6
Price/Sales6.09
Price/Book6.13

Competitors

 Today’s
change
Today’s
% change
ILMNIllumina Inc-0.23-0.11%
GILDGilead Sciences-0.15-0.19%
----
BIVVBioverativ Inc+0.16+0.27%
Data as of 10:41am ET, 10/18/2017

Financials

Next reporting dateOctober 24, 2017
EPS forecast (this quarter)$5.68
Annual revenue (last year)$10.2B
Annual profit (last year)$3.7B
Net profit margin36.32%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Michel Vounatsos
Senior Vice President-
US Therapeutic Operations
Alisha A. Alaimo
Corporate headquarters
Cambridge, Massachusetts

Forecasts